Target intelligence / Profile preview

Aryl hydrocarbon receptor pseudogene

Molecular classification
Pseudogene
01

Overview

The aryl hydrocarbon receptor pseudogene (ENSG00000219681) is a nonfunctional DNA segment in the human genome that resembles the functional aryl hydrocarbon receptor gene. Like most pseudogenes, it is classified as a noncoding genomic element with sequence similarity to its parent gene but lacks protein-coding ability due to disabling mutations or loss of necessary regulatory elements[3][4]. Pseudogenes may be transcribed at low levels; rarely, some bear regulatory functions such as acting as microRNA decoys or regulating parent gene expression, but most—including this one—are considered genetically nonfunctional[4]. It is not considered a therapeutic target, does not interact with approved drugs, and has no recognized role in disease or as a biomarker[3][4]. The designation 'pseudogene' reflects its origin (likely retrotransposition or duplication followed by mutational inactivation) and its primary classification as 'genomic junk' rather than a protein-coding gene or receptor[3][4][2]. If you need information on the functional aryl hydrocarbon receptor (AHR)—which is a bona fide receptor and therapeutic target—please clarify, as this record only refers to the nonfunctional pseudogene copy.

02

Biological functions

Genomic relicPotential microRNA decoyOther
03

Disease associations

Other

Beyond the preview

Go deeper on Aryl hydrocarbon receptor pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aryl hydrocarbon receptor pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call